FDA.reportPublic FDA data

1 ML triamcinolone acetonide 40 MG/ML Injection [Triesence]

RxCUI
1086259
RxNorm name
1 ML triamcinolone acetonide 40 MG/ML Injection [Triesence]
Display name
TRIESENCE (Injectable)
Full name
1 ML triamcinolone acetonide 40 MG/ML Injection [Triesence]
Term type
SBD
Status
Active
Strength
40 mg/ml
Dose form
Injection 1 ml
Route
Injectable
Updated
2026-06-14 07:05:37

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
022011
Active start
022011
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
triamcinolone acetonide40 MG / 1 MLtriamcinolonetriamcinolone acetonide

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Injection1649574

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
triamcinolone10759

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STR1 ML Triesence 40 MG/ML InjectionNAMES
RxNorm Name1 ML triamcinolone acetonide 40 MG/ML Injection [Triesence]NAMES
RxNorm Synonym1 ML Triesence 40 MG/ML InjectionNAMES
RxNorm SynonymTriesence 40 MG per 1 ML InjectionNAMES
TTYSBDATTRIBUTES
SPL_SET_ID2267978c-72ad-9229-e063-6394a90a09d0CODES
SPL_SET_ID22692d92-1359-9252-e063-6394a90ab669CODES
RxCUI1086259CODES
MMSL_CODEBD31448CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0078-0897-780078-0897TRIESENCE triamcinolone acetonideNovartis Pharmaceuticals CorporationNDA022048
82667-800-0182667-800TRIESENCE triamcinolone acetonideHarrow Eye, LLCNDA022048

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA0220480078-0897TRIESENCE triamcinolone acetonideNDANovartis Pharmaceuticals Corporation

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
00065054301rxnav_ndcsyes
00078089778rxnav_ndcsyes
82667080001rxnav_ndcsyes

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
2267978c-72ad-9229-e063-6394a90a09d01 ML Triesence 40 MG/ML InjectionSY3These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 195720251030
2267978c-72ad-9229-e063-6394a90a09d0Triesence 40 MG in 1 ML InjectionPSN3These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 195720251030
2267978c-72ad-9229-e063-6394a90a09d01 ML triamcinolone acetonide 40 MG/ML Injection [Triesence]SBD3These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 195720251030
2267978c-72ad-9229-e063-6394a90a09d0Triesence 40 MG per 1 ML InjectionSY3These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 195720251030
22692d92-1359-9252-e063-6394a90ab669Triesence 40 MG in 1 ML InjectionPSN2These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 195720260401
22692d92-1359-9252-e063-6394a90ab669Triesence 40 MG per 1 ML InjectionSY2These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 195720260401
22692d92-1359-9252-e063-6394a90ab6691 ML triamcinolone acetonide 40 MG/ML Injection [Triesence]SBD2These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 195720260401
22692d92-1359-9252-e063-6394a90ab6691 ML Triesence 40 MG/ML InjectionSY2These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 195720260401

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
2267978c-72ad-9229-e063-6394a90a09d0These highlights do not include all the information needed to use TRIESENCE safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 1957Harrow Eye, LLC | Alcon Research LLC20260605
22692d92-1359-9252-e063-6394a90ab669These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 1957Novartis Pharmaceuticals Corporation | Alcon Research LLC20260401
2267978c-72ad-9229-e063-6394a90a09d0These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 1957Harrow Eye, LLC | Alcon Research LLC20251030
2267978c-72ad-9229-e063-6394a90a09d0These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 1957Harrow Eye, LLC20240916

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC05AACorticosteroidsATC1-4triamcinolone
ATCR01ADCorticosteroidsATC1-4triamcinolone
ATCA01ACCorticosteroids for local oral treatmentATC1-4triamcinolone
ATCD07ABCorticosteroids, moderately potent (group II)ATC1-4triamcinolone
ATCD07XBCorticosteroids, moderately potent, other combinationsATC1-4triamcinolone
ATCS01BACorticosteroids, plainATC1-4triamcinolone
ATCR03BAGlucocorticoidsATC1-4triamcinolone
ATCH02ABGlucocorticoidsATC1-4triamcinolone
FDASPLN0000175576CorticosteroidEPChas_epctriamcinolone
FDASPLN0000175576CorticosteroidEPChas_epctriamcinolone acetonide
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moatriamcinolone acetonide
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moatriamcinolone
MEDRTD014221TriamcinoloneCHEMhas_ingredienttriamcinolone
MEDRTD014222Triamcinolone AcetonideCHEMhas_ingredienttriamcinolone acetonide
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treattriamcinolone acetonide
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treattriamcinolone
MEDRTD000743Anemia, HemolyticDISEASEmay_treattriamcinolone acetonide
MEDRTD000743Anemia, HemolyticDISEASEmay_treattriamcinolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventtriamcinolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventtriamcinolone acetonide
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventtriamcinolone
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventtriamcinolone acetonide
MEDRTD001249AsthmaDISEASEmay_preventtriamcinolone
MEDRTD001249AsthmaDISEASEmay_preventtriamcinolone acetonide
MEDRTD001607BerylliosisDISEASEmay_treattriamcinolone acetonide
MEDRTD001607BerylliosisDISEASEmay_treattriamcinolone
MEDRTD001986Bronchial SpasmDISEASEmay_treattriamcinolone
MEDRTD001986Bronchial SpasmDISEASEmay_treattriamcinolone acetonide
MEDRTD003093Colitis, UlcerativeDISEASEmay_treattriamcinolone
MEDRTD003093Colitis, UlcerativeDISEASEmay_treattriamcinolone acetonide
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treattriamcinolone
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treattriamcinolone acetonide
MEDRTD003876Dermatitis, AtopicDISEASEmay_treattriamcinolone acetonide
MEDRTD003876Dermatitis, AtopicDISEASEmay_treattriamcinolone
MEDRTD004342Drug HypersensitivityDISEASEci_withtriamcinolone acetonide
MEDRTD004342Drug HypersensitivityDISEASEci_withtriamcinolone
MEDRTD004892Erythema MultiformeDISEASEmay_treattriamcinolone
MEDRTD004892Erythema MultiformeDISEASEmay_treattriamcinolone acetonide
MEDRTD005148Facial DermatosesDISEASEmay_treattriamcinolone
MEDRTD005148Facial DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD005533Foot DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD005533Foot DermatosesDISEASEmay_treattriamcinolone
MEDRTD006229Hand DermatosesDISEASEmay_treattriamcinolone
MEDRTD006229Hand DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD006934HypercalcemiaDISEASEmay_treattriamcinolone acetonide
MEDRTD006934HypercalcemiaDISEASEmay_treattriamcinolone
MEDRTD007239InfectionsDISEASEci_withtriamcinolone acetonide
MEDRTD007239InfectionsDISEASEci_withtriamcinolone
MEDRTD007249InflammationDISEASEmay_treattriamcinolone acetonide
MEDRTD007249InflammationDISEASEmay_treattriamcinolone
MEDRTD007868Leg DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD007868Leg DermatosesDISEASEmay_treattriamcinolone
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treattriamcinolone acetonide
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treattriamcinolone
MEDRTD009103Multiple SclerosisDISEASEmay_treattriamcinolone
MEDRTD009103Multiple SclerosisDISEASEmay_treattriamcinolone acetonide
MEDRTD009181MycosesDISEASEci_withtriamcinolone
MEDRTD009181MycosesDISEASEci_withtriamcinolone acetonide
MEDRTD009404Nephrotic SyndromeDISEASEmay_treattriamcinolone acetonide
MEDRTD009404Nephrotic SyndromeDISEASEmay_treattriamcinolone
MEDRTD010392PemphigusDISEASEmay_treattriamcinolone
MEDRTD010392PemphigusDISEASEmay_treattriamcinolone acetonide
MEDRTD012216Rheumatic DiseasesDISEASEmay_treattriamcinolone acetonide
MEDRTD012216Rheumatic DiseasesDISEASEmay_treattriamcinolone
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treattriamcinolone
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treattriamcinolone acetonide
MEDRTD012536Scalp DermatosesDISEASEmay_treattriamcinolone acetonide
MEDRTD012536Scalp DermatosesDISEASEmay_treattriamcinolone
MEDRTD012713Serum SicknessDISEASEmay_treattriamcinolone
MEDRTD012713Serum SicknessDISEASEmay_treattriamcinolone acetonide
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treattriamcinolone acetonide
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treattriamcinolone
MEDRTD013224Status AsthmaticusDISEASEci_withtriamcinolone
MEDRTD013224Status AsthmaticusDISEASEci_withtriamcinolone acetonide
MEDRTD013585SynovitisDISEASEmay_treattriamcinolone acetonide
MEDRTD013585SynovitisDISEASEmay_treattriamcinolone
MEDRTD013966ThyroiditisDISEASEmay_treattriamcinolone
MEDRTD013966ThyroiditisDISEASEmay_treattriamcinolone acetonide
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treattriamcinolone acetonide
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treattriamcinolone
MEDRTD014605UveitisDISEASEmay_treattriamcinolone
MEDRTD014605UveitisDISEASEmay_treattriamcinolone acetonide
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moatriamcinolone acetonide
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moatriamcinolone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moatriamcinolone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moatriamcinolone acetonide
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_petriamcinolone acetonide
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_petriamcinolone
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_petriamcinolone
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_petriamcinolone acetonide
MEDRTN0000008571Decreased Cytokine ActivityPEhas_petriamcinolone acetonide
MEDRTN0000008571Decreased Cytokine ActivityPEhas_petriamcinolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_petriamcinolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_petriamcinolone acetonide
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_petriamcinolone acetonide
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_petriamcinolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_petriamcinolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_petriamcinolone acetonide
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_petriamcinolone acetonide
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_petriamcinolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_petriamcinolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_petriamcinolone acetonide
MEDRTN0000008841Decreased Protein SynthesisPEhas_petriamcinolone acetonide
MEDRTN0000008841Decreased Protein SynthesisPEhas_petriamcinolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_petriamcinolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_petriamcinolone acetonide
MEDRTN0000009739Lipid Metabolism AlterationPEhas_petriamcinolone acetonide
MEDRTN0000009739Lipid Metabolism AlterationPEhas_petriamcinolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_petriamcinolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_petriamcinolone acetonide

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH40 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESQUANTITY1 ML
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSBD
CODESMMSL_CODEBD31448
CODESNDANDA022048
CODESRxCUI1086259
CODESSPL_SET_ID2267978c-72ad-9229-e063-6394a90a09d0
CODESSPL_SET_ID22692d92-1359-9252-e063-6394a90ab669
NAMESPrescribable SynonymTriesence 40 MG in 1 ML Injection
NAMESRXNAV_STR1 ML Triesence 40 MG/ML Injection
NAMESRxNorm Name1 ML triamcinolone acetonide 40 MG/ML Injection [Triesence]
NAMESRxNorm Synonym1 ML Triesence 40 MG/ML Injection
NAMESRxNorm SynonymTriesence 40 MG per 1 ML Injection
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon